BackOutlook Therapeutics- Warrants Overview
Outlook Therapeutics Inc - Warrants - Series A (18/02/2022)

Outlook Therapeutics- Warrants Return on Equity

Return on Equity (ROE) for OTLKW.

Get informed when a big investor buys or sells

+ Follow

ROE

130.71%

Return on Equity

130.71%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

Average ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading